Until the end of January 2020. Fresenius Kabi will invest at least PLN 100 million in Kutno and create 45 jobs. The production plant in the £ód¼ Special Economic Zone (£SEZ) will house a new hall.
As part of the investment, the company will install modern production lines, as well as modernize and expand the existing quality control laboratory. Additionally, Fresenius Kabi will invest in social rooms for its employees.
Fresenius Kabi Polska Sp. z o.o. is a part of the international Fresenius Kabi concern and has been operating in Poland since 1999. The infusion fluids produced in Kutno are distributed both to Polish hospitals and exported.